유장

유장

오후 : 금
진료과

종양핵의학

의료진 소개

유장

핵의학과

유장

전문진료분야 / 종양핵의학
진료시간표
진료시간표 - 요일/오전오후 진료시간을 확인가능한 표
오전
오후 O

학력사항

  • 한양대학교 의과대학 의학사 (2008)
    성균관대학교 의과대학원 의학석사 (2012)
    성균관대학교 의과대학원 의학박사 (2019)

교육 및 연구 경력

  • 2024.3 ~ 현재 원주세브란스기독병원 핵의학과 임상진료교수
    2018.9 ~ 2024.2 중앙보훈병원 핵의학과 진료부장
    2018.3 ~ 2018.8 삼성서울병원 핵의학과 임상강사
    2016.5 ~ 2018.2 이대목동병원 핵의학과 전임의
    2009.3 ~ 2013.2 삼성서울병원 핵의학과 전공의

학술활동

  • 대한핵의학회, 미국핵의학회, 유럽핵의학회 정회원
    방사성동위원소취급자 특수면허
    USMLE ECFMG certificate

주요관심분야

  • 종양핵의학

강의분야

  • 종양핵의학

주요업적

  • (1) Yoo J, et al. Dynamic blood flow imaging with 99mTc-hydroxymethylene diphosphonate as a therapeutic response marker in patients with Raynaud's phenomenon. Sci Rep 2023;13(1):19751
    (2) Yoo J, et al. Radiomics analysis of 18F-FDG PET/CT for prognosis prediction in patients with stage III non-small cell lung cancer undergoing neoadjuvant chemoradiation. Cancers 2023;15(7):2012
    (3) Yoo J, et al. Predictive value of 18F-FDG PET/CT using machine learning for pathological response to neoadjuvant concurrent chemoradiotherapy in patients with stage III non-small cell lung cancer. Cancers 2022;14(8):1987
    (4) Yi HK, et al. Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization. Sci Rep 2022;12(1):12639
    (5) Cheon M, et al. Diagnostic performance for differential diagnosis of atypical Parkinsonian syndromes from Parkinson's disease using quantitative indices of 18F-FP-CIT PET/CT. Diagnostics 2022;12(6):1402
    (5) Yoo J, et al. Machine learning-based diagnostic method of pre-therapeutic 18F-FDG PET/CT for evaluating mediastinal lymph nodes in non-small cell lung cancer. Eur Radiol 2021;31(6):4184-4194
    (6) Kim D, et al. Image registration of 18F-FDG PET/CT using MotionFree algorithm and CT protocols through phantom study and clinical evaluation. Healthcare 2021;9(6):669
    (7) Cheon M, et al. Diagnostic performance of three-phase bone scintigraphy and digital infrared thermography imaging for chronic post-traumatic complex regional pain syndrome. Diagnostics 2021;11(8):1459
    (8) Kim DH, et al. Characterization of idiopathic Parkinson's disease subgroups using quantitative gait analysis and corresponding subregional striatal uptake visualized using 18F-FP-CIT positron emission tomography. Gait Posture 2020;82:167-173
    (9) Cheon M, et al. Diagnostic performance of 18F-Fluorodeoxyglucose Positron Emission Tomography/CT for chronic empyema-associated malignancy. Korean J Radiol 2019;20(8):1293-1299
    (10) Seo J, et al. A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification. J Neurosci Methods 2019;311:277-287
    (11) Yoo J, et al. Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI. PLoS One 2018;13(9):e0203649
    (12) Yoo J, et al. Predictive value of primary tumor parameters using 18F-FDG PET/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node. Ann Nucl Med 2018;32(9):642-648
    (13) Yoon H, et al. Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer. PLoS oNE 2018;13(4):e0196110
    (14) Yoo J, et al. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer. Ann Nucl Med 2018;32(5):328-336
    (15) Yoo J, et al. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI. Medicine 2017; 96(31):e7657
    (16) Yoon H, et al. Enhanced application of 18F-FDG PET/CT in bladder cancer by adding early dynamic acquisition to a standard delayed PET protocol. Clin Nucl Med 2017; 42(10):749-755
    (17) Yoon H, et al. Glucose metabolism of visceral adipose tissue measured by 18F-FDG PET/CT is related to the presence of colonic adenoma. Medicine 2017; 96(25):e7156
    (18) Yoo J, et al. Prognostic value of percentage change in metabolic parameters as measured by dual-time point 18F-FDG PET/CT in premenopausal women with invasive ductal breast carcinoma. J Womens Health 2017;26(10):1131-1137
    (19) Yoo J, et al. Prognostic value of primary tumor SUVmax on F-18 FDG PET/CT compared with semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer. Ann Nucl Med 2017;31(1):19-28
팝업닫기